New potential for enhancing concomitant chemoradiotherapy with FDA approved concentrations of cisplatin via the photoelectric effect

We predict, for the first time, that by using United States Food and Drug Administration approved concentrations of cisplatin, major radiosensitization may be achieved via photoelectric mechanism during concomitant chemoradiotherapy (CCRT). Our analytical calculations estimate that radiotherapy (RT)...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Phys Med
Главные авторы: Altundal, Yucel, Cifter, Gizem, Detappe, Alexandre, Sajo, Erno, Tsiamas, Panagiotis, Zygmanski, Piotr, Berbeco, Ross, Cormack, Robert A., Makrigiorgos, Mike, Ngwa, Wilfred
Формат: Artigo
Язык:Inglês
Опубликовано: 2014
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4492437/
https://ncbi.nlm.nih.gov/pubmed/25492359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejmp.2014.11.004
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы